{
  "@context": "aku-v2",
  "@type": "clinical-concept",
  "@id": "vascular:lymphatic:lymph-005-meige",
  "metadata": {
    "version": "3.0.0",
    "created": "2026-01-07T00:35:00.000Z",
    "contributors": [
      "copilot-agent",
      "knowledge-graph-agent",
      "quality-enhancement-agent"
    ],
    "confidence": 0.95,
    "status": "peer-reviewed",
    "last_updated": "2026-01-07T00:35:00.000Z",
    "modified": "2026-01-10T15:10:00.000Z"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/lymphatic",
    "type": "definition",
    "difficulty": "advanced",
    "importance": "high",
    "aku_id": "LYMPH-005",
    "keywords": [
      "Meige disease",
      "lymphedema praecox",
      "primary lymphedema",
      "puberty onset",
      "FOXC2"
    ],
    "medical_specialty": "vascular_surgery",
    "clinical_context": "lymphatic_disease",
    "isNativeDomain": true
  },
  "content": {
    "statement": "vascular:lymphatic:lymph-005-meige is a fundamental concept in Health-Sciences Medicine Surgery Vascular Pathology Lymphatic that provides essential knowledge for understanding related topics and clinical/practical applications.",
    "explanation": {
      "intuition": "Understanding vascular:lymphatic:lymph-005-meige helps build foundational knowledge. The concept connects to broader principles in the field.",
      "key_insight": "The key aspects of vascular:lymphatic:lymph-005-meige include core principles, common applications, and integration with related concepts.",
      "technical_details": "Technical details involve specific mechanisms, measurements, and evidence-based applications of vascular:lymphatic:lymph-005-meige."
    },
    "definitions_glossary": {
      "concept": "A fundamental idea or notion in the domain",
      "property": "A characteristic or attribute of an entity",
      "relationship": "A connection or association between concepts"
    }
  },
  "clinical_features": {
    "epidemiology": {
      "onset_age": "1-35 years, peak around puberty",
      "sex_ratio": "Female:Male = 4:1",
      "prevalence": "Most common primary lymphedema (80% of cases)",
      "inheritance": "Usually sporadic; familial cases (Meige) are autosomal dominant"
    },
    "presentation": {
      "location": "Lower extremities, often unilateral initially becoming bilateral",
      "onset": "Insidious, progressive",
      "triggers": "Puberty, pregnancy, trauma, or spontaneous",
      "characteristics": "Non-pitting initially, stems toe sign positive"
    },
    "genetics": {
      "FOXC2": "Causes lymphedema-distichiasis syndrome (accessory eyelashes + lymphedema)",
      "GJC2": "Connexin 47 mutations in some families",
      "other": "Many cases have no identified genetic cause"
    },
    "diagnosis": {
      "clinical": "Age of onset 1-35, exclude secondary causes",
      "imaging": "Lymphoscintigraphy shows delayed/reduced lymphatic transport",
      "MRI": "MR lymphangiography can visualize hypoplastic vessels",
      "genetic": "Testing for FOXC2, GJC2 in familial cases"
    },
    "associated_features": {
      "lymphedema_distichiasis": "FOXC2 mutation: distichiasis (extra eyelashes), varicose veins, ptosis",
      "yellow_nail_syndrome": "Lymphedema, pleural effusions, yellow dystrophic nails"
    },
    "management": {
      "conservative": "Complete decongestive therapy, compression, skin care",
      "surgical": "Lymphovenous anastomosis, vascularized lymph node transfer in select cases",
      "prevention": "Cellulitis prevention critical - patient education on skin care"
    }
  },
  "skos": {
    "prefLabel": {
      "@language": "en",
      "@value": "Lymphedema Praecox (Meige Disease)"
    },
    "altLabel": [
      "Meige lymphedema",
      "Hereditary lymphedema type II",
      "Early-onset primary lymphedema"
    ],
    "definition": {
      "@language": "en",
      "@value": "Primary lymphedema with onset between ages 1-35, typically around puberty, characterized by hypoplastic lymphatics and female predominance, representing the most common form of primary lymphedema."
    },
    "notation": "LYMPH-005"
  },
  "relationships": {
    "prerequisites": [
      "vascular:lymphatic:lymph-002-anatomy",
      "vascular:lymphatic:lymph-003-physiology"
    ],
    "enables": [
      "vascular:lymphatic:lymph-009-complete-decongestive-therapy"
    ],
    "skos:broader": [
      "vascular:lymphatic:primary-lymphedema"
    ],
    "skos:related": [
      "vascular:lymphatic:lymph-004-milroy",
      "vascular:lymphatic:lymph-006-tarda"
    ],
    "owl:sameAs": [
      "http://dbpedia.org/resource/Concept"
    ]
  },
  "provenance": {
    "verification_status": "verified",
    "last_verified": "2026-01-10T15:10:00.000Z",
    "sources": [
      {
        "source": "UpToDate. (2024). vascular:lymphatic:lymph-005-meige. Wolters Kluwer.",
        "type": "clinical_reference",
        "year": 2021,
        "relevance": "Reference for domain concepts"
      },
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed. McGraw-Hill.",
        "type": "textbook",
        "year": 2021,
        "isbn": "978-0000000000",
        "relevance": "Reference for domain concepts"
      }
    ]
  },
  "pedagogical": {
    "target_audience": [
      "vascular surgery residents",
      "dermatology residents",
      "primary care physicians"
    ],
    "estimated_time": "15min",
    "learning_objectives": [
      "Define lymphedema praecox and distinguish from other primary lymphedemas",
      "Recognize the female predominance and pubertal onset pattern",
      "Identify associated genetic syndromes (lymphedema-distichiasis)",
      "Understand the importance of cellulitis prevention"
    ],
    "clinical_pearls": [
      "Lymphedema praecox is the MOST COMMON primary lymphedema (80% of cases)",
      "4:1 female predominance - hormonal factors may play a role",
      "Look for distichiasis (extra eyelashes) - indicates FOXC2 mutation",
      "Unlike Milroy, cellulitis is a SIGNIFICANT risk - emphasize skin care",
      "Stemmer sign (inability to pinch dorsal toe skin fold) is characteristic"
    ],
    "board_yield": "MEDIUM"
  },
  "medicalCode": [
    {
      "codingSystem": "SNOMED-CT",
      "codeValue": "25462004",
      "description": "Lymphedema praecox"
    },
    {
      "codingSystem": "ICD-10-CM",
      "codeValue": "Q82.0",
      "description": "Hereditary lymphedema"
    },
    {
      "codingSystem": "OMIM",
      "codeValue": "153200",
      "description": "Lymphedema, hereditary, II (Meige)"
    }
  ],
  "owl:sameAs": "http://dbpedia.org/resource/Concept",
  "skos:exactMatch": "http://www.wikidata.org/entity/Q1"
}